About: Saratoga Opthalmology

Posts by Saratoga Opthalmology:

Week in review: COVID complication, hummingbird hues, pigmentosa puzzle

This week, a patient with COVID-19 experiences orbital emphysema, scientists provide a peek into how hummingbirds distinguish colors and new studies challenge researchers’ understanding of retinitis pigmentosa 59. Source: AAO

Posted on: Jun 26 2020
By: Saratoga Opthalmology
Leave a reponse

The growing role of educational podcasts among retina specialists

This survey study sought to investigate the perceived educational impact of podcasts and other materials on the general retina community. Source: AAO

Posted on: Jun 25 2020
By: Saratoga Opthalmology
Leave a reponse

Grid and quadrant patterns permit less energy consumption in soft and hard nuclei

This prospective, randomized clinical trial compared the efficacy and safety of 3 fragmentation patterns in eyes undergoing femtosecond laser-assisted cataract surgery (FLACS). Source: AAO

Posted on: Jun 24 2020
By: Saratoga Opthalmology
Leave a reponse

Ultrasound can be used to identify eyes with dysthyroid optic neuropathy

This study evaluated the optic nerve sheath diameter in eyes with dysthyroid optic neuropathy. Source: AAO

Posted on: Jun 23 2020
By: Saratoga Opthalmology
Leave a reponse

Can hydrogen peroxide vapor effectively decontaminate N95 respirators?

Researchers from Duke University assessed whether N95 respirators could be decontaminated using hydrogen peroxide vapor. Source: AAO

Posted on: Jun 22 2020
By: Saratoga Opthalmology
Leave a reponse

Week in review: Drug shortage, vitamin A, text help

This week, several ophthalmic drugs appear on the FDA’s shortage list, a vitamin A analog shows promise for early diabetic retinopathy and an SMS texting system could streamline patient encounters during the pandemic. Source: AAO

Posted on: Jun 19 2020
By: Saratoga Opthalmology
Leave a reponse

New NMOSD drug approved by the FDA

Inebilizumab (Uplizna) has been cleared for neuromyelitis optica spectrum disorder (NMOSD). The monotherapy drug is now the first and only B cell-depleting antibody approved for the disease. Source: AAO

Posted on: Jun 18 2020
By: Saratoga Opthalmology
Leave a reponse

Retinal vasculitis, inflammation linked to brolucizumab injections

This retrospective study evaluated the features and outcomes of eyes with retinal vasculitis and inflammation after brolucizumab treatment for neovascular AMD. Source: AAO

Posted on: Jun 18 2020
By: Saratoga Opthalmology
Leave a reponse

Conjunctivitis could be the only presenting sign and symptom of COVID-19

This case study details 5 patients with nonremitting conjunctivitis that was the sole presenting sign and symptom of COVID-19. Source: AAO

Posted on: Jun 17 2020
By: Saratoga Opthalmology
Leave a reponse

Smartphone-based immunoassay holds promise for at-home DR screening

This study evaluated a smartphone-based, gold nanoparticle-based immunoassay paper sensor for identifying a biomarker for diabetic retinopathy (DR). Source: AAO